Patents by Inventor Matthew Titlow
Matthew Titlow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12697340Abstract: Compositions and methods are presented that that help reduce cellular ageing, improve cellular stress resilience, and/or promote increased longevity. Especially preferred compositions include a combination of a purine alkaloid, an isothiocyanate or thioglucoside, and a metal-containing antioxidant, where the purine alkaloid, the isothiocyanate or thioglucoside, and the metal-containing antioxidant may be chemically isolated compounds or extracts or other preparations from naturally occurring entities such as plants, bacteria, yeast, etc. Advantageously, contemplated compositions will be effective to reduce and repair oxidative stress, improve mitochondrial function, augment DNA repair and telomere maintenance, increase fatty acid metabolism, and modulate histone deacetylation.Type: GrantFiled: November 3, 2021Date of Patent: August 4, 2026Assignee: JUVN3 HOLDINGS, LLCInventors: Hector L. Lopez, Tim Ziegenfuss, Matthew Titlow
-
Publication number: 20260053767Abstract: Orally administered low-dose formulations for medium chain di-carboxylic acids have unexpectedly a numerous of beneficial cytoprotective effects in a variety of cells. In particular, contemplated formulations compositions and methods reduce, reverse, and/or prevent liver inflammation, hepatic steatosis, and/or liver fibrosis in NASH, improve blood glucose control, and provide additional cytoprotective benefits such as stimulation of mitochondrial biogenesis, increased SIRT and NAMPT levels, increased NAD+, antioxidant capacity, and/or reduction of DNA damage.Type: ApplicationFiled: May 8, 2023Publication date: February 26, 2026Applicant: Jemyll, Ltd.Inventors: Giulia Angelini, Matthew Titlow, Timothy Shawn Avila
-
Publication number: 20260034137Abstract: Compositions and methods are presented that that help reduce cellular ageing, improve cellular stress resilience, and/or promote increased longevity. Especially preferred compositions include a combination of a purine alkaloid, an isothiocyanate or thioglucoside, and a metal-containing antioxidant, where the purine alkaloid, the isothiocyanate or thioglucoside, and the metal-containing antioxidant may be chemically isolated compounds or extracts or other preparations from naturally occurring entities such as plants, bacteria, yeast, etc. Advantageously, contemplated compositions will be effective to reduce and repair oxidative stress, improve mitochondrial function, augment DNA repair and telomere maintenance, increase fatty acid metabolism, and modulate histone deacetylation.Type: ApplicationFiled: July 1, 2025Publication date: February 5, 2026Applicant: JUVN3 Holdings, LLCInventors: Hector L. Lopez, Tim Ziegenfuss, Matthew Titlow
-
Publication number: 20250381214Abstract: An autobiotic composition includes a prebiotic component and postbiotic component. The prebiotic component is a substance resistant to digestion in the stomach and small intestine and selectively fermentable by microorganisms in the large intestine. The postbiotic component is a short-chain fatty acid, such as butyric acid, lactic acid, succinic acid, or salt or ester thereof, such as tributyrin. An autobiotic composition beneficially combines the microbiome-enhancing effects of a prebiotic with the intestinal healing effects of a postbiotic to provide overall benefits to digestive health. A seedbiotic component may form part of or be co-administered with the autobiotic composition. Enzymes may form part of or be co-administered with the autobiotic composition to enhance digestion of the prebiotic in the stomach and intestine and/or increase microbiome health. An exogenous ketone body component may form part of or be co-administered with the autobiotic composition.Type: ApplicationFiled: September 3, 2025Publication date: December 18, 2025Inventors: Gary Millet, Matthew Titlow
-
Patent number: 12472200Abstract: An autobiotic composition includes a prebiotic component and postbiotic component. The prebiotic component is a substance resistant to digestion in the stomach and small intestine and selectively fermentable by microorganisms in the large intestine. The postbiotic component is a short-chain fatty acid, such as butyric acid, lactic acid, succinic acid, or salt or ester thereof, such as tributyrin. An autobiotic composition beneficially combines the microbiome-enhancing effects of a prebiotic with the intestinal healing effects of a postbiotic to provide overall benefits to digestive health. A seedbiotic component may form part of or be co-administered with the autobiotic composition. Enzymes may form part of or be co-administered with the autobiotic composition to enhance digestion of the prebiotic in the stomach and intestine and/or increase microbiome health. An exogenous ketone body component may form part of or be co-administered with the autobiotic composition.Type: GrantFiled: May 14, 2020Date of Patent: November 18, 2025Assignees: AXCESS GLOBAL SCIENCES, LLCInventors: Gary Millet, Matthew Titlow
-
Patent number: 12433912Abstract: A method of administering an autobiotic composition that includes a prebiotic component and postbiotic component. The prebiotic component is a substance resistant to digestion in the stomach and small intestine and selectively fermentable by microorganisms in the large intestine. The postbiotic component is a short-chain fatty acid, such as butyric acid, lactic acid, succinic acid, or salt or ester thereof. The prebiotic component is advantageously delivered to the stomach and/or small intestine and the postbiotic is advantageously delivered to the large intestine. A seedbiotic component may form part of or be co-administered with the autobiotic composition. Enzymes may form part of or be co-administered with the autobiotic composition to enhance digestion of the prebiotic in the stomach and intestine and/or increase microbiome health. An exogenous ketone body component may form part of or be co-administered with the autobiotic composition.Type: GrantFiled: August 26, 2024Date of Patent: October 7, 2025Assignee: AXCESS GLOBAL SCIENCES, LLCInventors: Gary Millet, Matthew Titlow
-
Publication number: 20240415870Abstract: A method of administering an autobiotic composition that includes a prebiotic component and postbiotic component. The prebiotic component is a substance resistant to digestion in the stomach and small intestine and selectively fermentable by microorganisms in the large intestine. The postbiotic component is a short-chain fatty acid, such as butyric acid, lactic acid, succinic acid, or salt or ester thereof. The prebiotic component is advantageously delivered to the stomach and/or small intestine and the postbiotic is advantageously delivered to the large intestine. A seedbiotic component may form part of or be co-administered with the autobiotic composition. Enzymes may form part of or be co-administered with the autobiotic composition to enhance digestion of the prebiotic in the stomach and intestine and/or increase microbiome health. An exogenous ketone body component may form part of or be co-administered with the autobiotic composition.Type: ApplicationFiled: August 26, 2024Publication date: December 19, 2024Inventors: Gary MILLET, Matthew TITLOW
-
Patent number: 11925645Abstract: An enhanced caffeinated beverage composition includes a caffeinated drink combined with an effective blend of methylliberine and theacrine providing increased mood, energy, alertness, focus, motivation, and/or decreased fatigue without adversely affecting heart rate or blood pressure.Type: GrantFiled: February 21, 2023Date of Patent: March 12, 2024Assignee: ORTHO-NUTRA, LLCInventors: Hector L. Lopez, Tim N. Ziegenfuss, Matthew Titlow
-
Publication number: 20230263746Abstract: Compositions and methods are provided to increase the healthspan of a subject. Most typically, contemplated compositions are formulated for oral administration and comprise a synergistic combination of a first and a second polyamine (e.g., spermine and spermidine).Type: ApplicationFiled: February 23, 2023Publication date: August 24, 2023Applicant: Compound Solutions Inc.Inventor: Matthew Titlow
-
Publication number: 20230219881Abstract: A simplified synthetic process for production of spermine and spermidine are presented that can provide spermine and spermidine in free base or salt form. Advantageously, the synthetic procedure is safe, simple, and environmentally friendly, while at the same time also being cost-effective.Type: ApplicationFiled: December 20, 2022Publication date: July 13, 2023Applicants: Compound Solutions Inc., Shaoxing King-Year Biochemical Co., Ltd.Inventors: Matthew Titlow, Xinglong Gu
-
Publication number: 20230190757Abstract: An enhanced caffeinated beverage composition includes a caffeinated drink combined with an effective blend of methylliberine and theacrine providing increased mood, energy, alertness, focus, motivation, and/or decreased fatigue without adversely affecting heart rate or blood pressure.Type: ApplicationFiled: February 21, 2023Publication date: June 22, 2023Applicant: Ortho-Nutra, LLCInventors: Hector L. Lopez, Tim N. Ziegenfuss, Matthew Titlow
-
Publication number: 20230149488Abstract: Compositions and methods are presented that help reduce cellular ageing, improve cellular stress resilience, and/or promote increased longevity. Especially preferred compositions include a combination of a purine alkaloid, an isothiocyanate or thioglucoside, and a metal-containing antioxidant, where the purine alkaloid, the isothiocyanate or thioglucoside, and the metal-containing antioxidant may be chemically isolated compounds or extracts or other preparations from naturally occurring entities such as plants, bacteria, yeast, etc. Advantageously, contemplated compositions will be effective to reduce and repair oxidative stress, improve mitochondrial function, augment DNA repair and telomere maintenance, increase fatty acid metabolism, and modulate histone deacetylation.Type: ApplicationFiled: December 17, 2019Publication date: May 18, 2023Applicants: JUVN3 Holdings, LLC, JUVN3 Holdings, LLCInventors: Hector L. Lopez, Tim Ziegenfuss, Matthew Titlow
-
Publication number: 20230149412Abstract: Compositions and methods are presented that that help reduce cellular ageing, improve cellular stress resilience, and/or promote increased longevity. Especially preferred compositions include a combination of a purine alkaloid, an isothiocyanate or thioglucoside, and a metal-containing antioxidant, where the purine alkaloid, the isothiocyanate or thioglucoside, and the metal-containing antioxidant may be chemically isolated compounds or extracts or other preparations from naturally occurring entities such as plants, bacteria, yeast, etc. Advantageously, contemplated compositions will be effective to reduce and repair oxidative stress, improve mitochondrial function, augment DNA repair and telomere maintenance, increase fatty acid metabolism, and modulate histone deacetylation.Type: ApplicationFiled: November 3, 2021Publication date: May 18, 2023Applicant: JUVN3 Holdings, LLCInventors: Hector L. Lopez, Tim Ziegenfuss, Matthew Titlow
-
Patent number: 11583534Abstract: An enhanced caffeinated beverage composition includes a caffeinated drink combined with an effective blend of methylliberine and theacrine providing increased mood, energy, alertness, focus, motivation, and/or decreased fatigue without adversely affecting heart rate or blood pressure.Type: GrantFiled: October 30, 2020Date of Patent: February 21, 2023Assignee: Ortho-Nutra, LLCInventors: Hector L Lopez, Tim N. Ziegenfuss, Matthew Titlow
-
Publication number: 20230025435Abstract: Compositions and methods are presented that help reduce cellular ageing, improve cellular stress resilience, and/or promote increased longevity. Exemplary compositions include a combination of a purine alkaloid, an isothiocyanate or thioglucoside, a metal-containing antioxidant, and optionally an additional ingredient, where the purine alkaloid, the isothiocyanate or thioglucoside, and the metal-containing antioxidant may be chemically isolated compounds or extracts or other preparations from naturally occurring entities such as plants, bacteria, yeast, etc. Advantageously, contemplated compositions are effective to reduce and repair oxidative stress, improve mitochondrial function, augment DNA repair and telomere maintenance, increase fatty acid metabolism, and modulate histone deacetylation. More specifically, the contemplated compositions are capable of increasing cellular vitality by inducing expression of OCT4, SOX, and/or KLF4 and/or decreasing biomarkers of cell senescence.Type: ApplicationFiled: January 6, 2021Publication date: January 26, 2023Applicant: JUVN3 Holdings, LLCInventors: Tim N. Ziegenfuss, Matthew Titlow, Hector L. Lopez
-
Patent number: 11141442Abstract: Tributyrin and/or tributyrin derivatives are used to selectively increase the levels of Bifidobacteria in the gut. In preferred methods, the tributyrin and/or tributyrin derivatives are orally administered alone or in combination with a food item or other nutritionally acceptable carrier, and may further include Bifidobacteria. Tributyrin-enhanced Bifidobacterium strains are also contemplated that include Bifidobacteria previously cultured in tributyrin and/or tributyrin derivatives.Type: GrantFiled: June 6, 2019Date of Patent: October 12, 2021Assignee: Compound Solutions, Inc.Inventor: Matthew Titlow
-
Patent number: 11045509Abstract: Tributyrin and/or tributyrin derivatives are used to selectively increase the levels of Bifidobacteria in the gut. In preferred methods, the tributyrin and/or tributyrin derivatives are orally administered alone or in combination with a food item or other nutritionally acceptable carrier, and may further include Bifidobacteria. Tributyrin-enhanced Bifidobacterium strains are also contemplated that include Bifidobacteria previously cultured in tributyrin and/or tributyrin derivatives.Type: GrantFiled: July 23, 2019Date of Patent: June 29, 2021Assignee: COMPOUND SOLUTIONS, INC.Inventor: Matthew Titlow
-
Publication number: 20210137928Abstract: An enhanced caffeinated beverage composition includes a caffeinated drink combined with an effective blend of methylliberine and theacrine providing increased mood, energy, alertness, focus, motivation, and/or decreased fatigue without adversely affecting heart rate or blood pressure.Type: ApplicationFiled: October 30, 2020Publication date: May 13, 2021Applicant: Ortho-Nutra, LLCInventors: Hector L Lopez, Tim N. Ziegenfuss, Matthew Titlow
-
Publication number: 20200384042Abstract: Tributyrin and/or tributyrin derivatives are used to selectively increase the levels of Bifidobacteria in the gut. In preferred methods, the tributyrin and/or tributyrin derivatives are orally administered alone or in combination with a food item or other nutritionally acceptable carrier, and may further include Bifidobacteria. Tributyrin-enhanced Bifidobacterium strains are also contemplated that include Bifidobacteria previously cultured in tributyrin and/or tributyrin derivatives.Type: ApplicationFiled: June 6, 2019Publication date: December 10, 2020Inventor: Matthew Titlow
-
Publication number: 20200384043Abstract: Tributyrin and/or tributyrin derivatives are used to selectively increase the levels of Bifidobacteria in the gut. In preferred methods, the tributyrin and/or tributyrin derivatives are orally administered alone or in combination with a food item or other nutritionally acceptable carrier, and may further include Bifidobacteria. Tributyrin-enhanced Bifidobacterium strains are also contemplated that include Bifidobacteria previously cultured in tributyrin and/or tributyrin derivatives.Type: ApplicationFiled: July 23, 2019Publication date: December 10, 2020Inventor: Matthew Titlow